AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe

AdBio partners’ unique strategy combines early-stage investments in promising startups and strong entrepreneurial support to enable and strengthen the company’s growth.

As an early-stage investor, we act as a catalyst to create companies based on innovations coming from academic research. We have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of strong network of scientific, clinical, industry and financial partners.

The operational team is managed by Alain Huriez, MD, chairman, and Matthieu Coutet, managing partner; it includes seasoned investment professionals with long-standing track records in entrepreneurial ventures, combined with strong scientific and medical expertise.